Evidence mapPaperPMID 42529640Full record

ArticleFrontiers in public health2026

International advocacy for ketogenic diet research in schizophrenia: insights from a public petition.

Sidney L Murray, Daniel J O Roche, Christopher M Palmer, Shuo Chen, Hwiyoung Lee, Gopal Vyas, Heather A Adams, Valerie Harrington, Deanna L Kelly

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sidney L MurrayMaryland Psychiatric Research Center, Catonsville, MD, United States.
Daniel J O RocheMaryland Psychiatric Research Center, Catonsville, MD, United States.
Christopher M PalmerHarvard Medical School, Boston, MA, United States.
Shuo ChenUniversity of Maryland Baltimore School of Medicine, Baltimore, MD, United States.
Hwiyoung LeeUniversity of Maryland Baltimore School of Medicine, Baltimore, MD, United States.
Gopal VyasMaryland Psychiatric Research Center, Catonsville, MD, United States.
Heather A AdamsMaryland Psychiatric Research Center, Catonsville, MD, United States.
Valerie HarringtonMaryland Psychiatric Research Center, Catonsville, MD, United States.
Deanna L KellyMaryland Psychiatric Research Center, Catonsville, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is associated with substantial disability, persistent symptoms, and significant unmet treatment needs. The ketogenic diet has emerged as a metabolic intervention of growing interest for serious mental illness. This study reports quantitative and qualitative findings from a large international Change.org petition advocating for the resumption of a halted randomized blinded inpatient study investigating a ketogenic diet intervention for individuals with schizophrenia. The petition received 21,637 signatures and 1,105 comments from individuals across 151 countries. Participant comments were analyzed using top-down theme consensus coding and Latent Dirichlet Allocation (LDA) topic modeling. Results revealed widespread interest in nutritional and metabolic approaches to mental health, concerns regarding the limitations of current treatment options, and support for further investigation of ketogenic interventions in schizophrenia. Many petitioners described personal or observed experiences with ketogenic diets and emphasized the need for additional research. As this was a self-selected advocacy-driven sample, findings may overrepresent individuals supportive of ketogenic diet research and are not representative of the broader population. These findings provide insight into the perspectives and experiences of petitioners and highlight interest in expanding research on novel treatment approaches for schizophrenia, such as ketogenic dietary interventions.

Indexed as

Diet, KetogenicPatient AdvocacySchizophreniaHumansdietary interventionsketogenic dietmental healthpetitionresearch advocacyschizophrenia

Identifiers

PMID42529640
PMCPMC13418445

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.